Table 2. Associations between expression levels of miR-495 and clinical parameters.
| median ± SD | P value | |
|---|---|---|
| Gender | 0.754 | |
| Male | −19.4 ± 9.5 | |
| Female | −24.2 ± 8.4 | |
| Age | 0.453 | |
| < 55 | −19.5 ± 6.5 | |
| ≥ 55 | −23.6 ± 11.3 | |
| LNM | 0.017 | |
| N0 | −11.1 ± 5.1 | |
| N1 | −21.1 ± 7.2 | |
| N2 | −49.3 ± 6 | |
| Invasion | 0.004 | |
| T1 | −5.5 ± 3.7 | |
| T2 | −15.9 ± 2.8 | |
| T3 | −29.4 ± 6.4 | |
| T4a | −47.3 ± 8.9 | |
| Histological type | 0.132 | |
| Ulcerative | −16.8 ± 8.8 | |
| Medullary | −15.2 ± 5.9 | |
| Fungating | −25.3 ± 6.7 | |
| Others | −35.0 ± 11.9 | |
| TNM stage | 0.036 | |
| I | −0.3 ± 0.2 | |
| II a | −2.1 ± 1.1 | |
| II b | −19.5 ± 10.0 | |
| III | −44.3 ± 11.4 |